
---
title: '双成药业：董事、高管拟减持公司股份'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=168'
author: 证券时报网
comments: false
date: Sun, 15 May 2022 16:54:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=168'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002693" style="color: #2f67d1;text-decoration: none;" code="002693" target="_blank">双成药业</a>5月15日晚公告，董事、总经理 JIANMING LI，副总经理袁剑琳，副总经理张巍，财务总监王旭光，副总经理、董事会秘书于晓风等拟减持公司股份，合计拟减持股份占公司总股本的比例不超过0.28%。<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ002693" style="color: #2f67d1;text-decoration: none;" code="002693" target="_blank">双成药业</a>近期因肝炎概念股价连续大涨。</p>

                  
</div>
            